These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26229400)
1. Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice. Koh SJ; Kim JW; Kim BG; Lee KL; Kim JS World J Gastroenterol; 2015 Jul; 21(28):8580-7. PubMed ID: 26229400 [TBL] [Abstract][Full Text] [Related]
2. Aggravation of Established Colitis in Specific Pathogen-free IL-10 Knockout Mice by Restraint Stress Is Not Mediated by Increased Colonic Permeability. Schultz M; Lai CC; Lindstroem AL; Stein K; Donaldson G; Thompson-Fawcett M; Butt AG J Crohns Colitis; 2015 Sep; 9(9):754-62. PubMed ID: 26048917 [TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice. Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease. Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255 [TBL] [Abstract][Full Text] [Related]
5. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice. Zhang H; Xue Y; Wang H; Huang Y; Du M; Yang Q; Zhu MJ World J Gastroenterol; 2014 Jul; 20(27):9106-15. PubMed ID: 25083083 [TBL] [Abstract][Full Text] [Related]
6. Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression. Lee SD; Choe JW; Lee BJ; Kang MH; Joo MK; Kim JH; Yeon JE; Park JJ; Kim JS; Bak YT World J Gastroenterol; 2015 Jan; 21(2):465-74. PubMed ID: 25593461 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis. Fujimoto Y; Azuma YT; Matsuo Y; Kuwamura M; Kuramoto N; Miki M; Azuma N; Teramoto M; Nishiyama K; Izawa T; Nakajima H; Takeuchi T Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):261-268. PubMed ID: 27942772 [TBL] [Abstract][Full Text] [Related]
8. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production. Nakagawa T; Katsuno T; Noguchi Y; Mandai Y; Yoshihama S; Saito K; Maruoka D; Matsumura T; Arai M; Yokosuka O Biol Pharm Bull; 2015; 38(11):1681-8. PubMed ID: 26521820 [TBL] [Abstract][Full Text] [Related]
9. Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice. Lennon EM; Maharshak N; Elloumi H; Borst L; Plevy SE; Moeser AJ Inflamm Bowel Dis; 2013; 19(4):712-9. PubMed ID: 23446335 [TBL] [Abstract][Full Text] [Related]
10. Physiological stress exacerbates murine colitis by enhancing proinflammatory cytokine expression that is dependent on IL-18. Matsunaga H; Hokari R; Ueda T; Kurihara C; Hozumi H; Higashiyama M; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Sekiyama A; Miura S Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G555-64. PubMed ID: 21719737 [TBL] [Abstract][Full Text] [Related]
12. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Berg DJ; Zhang J; Weinstock JV; Ismail HF; Earle KA; Alila H; Pamukcu R; Moore S; Lynch RG Gastroenterology; 2002 Nov; 123(5):1527-42. PubMed ID: 12404228 [TBL] [Abstract][Full Text] [Related]
13. GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice. Zhao J; Wang H; Shi P; Wang W; Sun Y Oncotarget; 2017 Jan; 8(5):8397-8405. PubMed ID: 28039475 [TBL] [Abstract][Full Text] [Related]
14. Expression patterns of sirtuin 1-AMPK-autophagy pathway in chronic colitis and inflammation-associated colon neoplasia in IL-10-deficient mice. Talero E; Alcaide A; Ávila-Román J; García-Mauriño S; Vendramini-Costa D; Motilva V Int Immunopharmacol; 2016 Jun; 35():248-256. PubMed ID: 27085036 [TBL] [Abstract][Full Text] [Related]
15. Induction of chronic colitis in IL-10 deficient mice requires IL-4. Specht S; Arriens S; Hoerauf A Microbes Infect; 2006 Mar; 8(3):694-703. PubMed ID: 16513385 [TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis. Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model. del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117 [TBL] [Abstract][Full Text] [Related]
18. NHE3 modulates the severity of colitis in IL-10-deficient mice. Larmonier CB; Laubitz D; Thurston RD; Bucknam AL; Hill FM; Midura-Kiela M; Ramalingam R; Kiela PR; Ghishan FK Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G998-G1009. PubMed ID: 21415416 [TBL] [Abstract][Full Text] [Related]
19. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. Yadav M; Huang MC; Goetzl EJ Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288 [TBL] [Abstract][Full Text] [Related]